Agranulocytosis monitoring with Clozapine: To follow guidelines or to attempt therapeutic controversies?

Singapore Medical Journal

Volumn 49, Issue 2, 2008, Pages 96-99

  Chandrasekaran, Prem Kumar ^a  

^a Penang Adventist Hospital   (Malaysia)

Author keywords

Agranulocytosis; Antipsychotic drugs; Clozapine; Refractory schizophrenia; Schizophrenia

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; MIANSERIN; OLANZAPINE; PHENYLBUTAZONE; NEUROLEPTIC AGENT;

AGRANULOCYTOSIS; BLOOD EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FLU LIKE SYNDROME; GENETIC POLYMORPHISM; HUMAN; LEUKOPENIA; MEDICOLEGAL ASPECT; PATIENT MONITORING; PRACTICE GUIDELINE; PSEUDONEUTROPENIA; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; THROMBOCYTOPENIA; CHEMICALLY INDUCED DISORDER; DEVELOPING COUNTRY; DRUG MONITORING; LEGAL LIABILITY; METHODOLOGY; PATIENT EDUCATION;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DEVELOPING COUNTRIES; DRUG MONITORING; HUMANS; LIABILITY, LEGAL; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; SCHIZOPHRENIA;

EID: 40749096457     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. McGrath J. New antipsychotic medications. Aust Prescr 1999; 22:81-3.
2. Mahendran R. Leucopenia and thrombocytopenia induced by Clozapine. Hong Kong J Psychiatry 2002; 12:19-20.
3. Norvatis Corporation. Clozaril prescribers guide. 2000 Jan.
4. Kaladjian A, Bery B, Deturmeny E, Bruguerolle B. Clozapine Monitoring: Plasma or serum levels? Ther Drug Monit 1999; 21:327-9.
5. Ahokas A, Elonen E. Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology (Berl)1999; 144:301-2.
6. Honigfeld G. WBC counts reduced to monthly for FazaClo orally disintegrating tablets patients after one year. [online] 2005 May. Available at: www.fazaclo.com/. Accessed November 10, 2006
7. United States Food and Drug Administration Centre for Drug Evaluation and Research. Pharmacologic Drugs Advisory Committee, 48th Meeting (1997 Jul 14).
8. Schulte PF. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann Pharmacother 2006; 40:683-8.